"Satellite V" gives ghost effects only at 1% vaccinated

2021: Sputnik V gives side effects in only 1% of those vaccinated in Argentina

In early January 2021 Ministry of Health of Argentina (Ministry of Health) , it published a report on the use of Russian. coronavirus vaccines COVID-19 "Satellite V" According to the agency, complications were detected only in 1% of people who were vaccinated with this drug.

Side effects were detected in 317 people out of more than 32 thousand vaccinated in Argentina. Almost one in two who complained of complications after vaccination indicated increased fever, headaches and muscle pain. Another 25.6% said only headaches and muscle pains, 11.4% vaccinated - about elevated temperature, another 1.3% of patients found allergies without other negative consequences.

Sputnik V vaccine gives side effects in only 1% of those vaccinated in Argentina

According to the study methodology, a complication in the patient is any deterioration that occurred after vaccination, even if it is not directly related to the use of the drug. Of all patients who have experienced complications, 94% (298 individuals) are believed to be associated with vaccine side effects. In another 6%, complications were associated with diseases and injuries that occurred before vaccination, or with an error in diagnosis.

The Argentine Ministry of Health noted that in most cases (99.3%) they were talking about symptoms of mild or moderate severity. Hospitalization was not required with them, these patients fully recovered.

Sputnik V was the first coronavirus vaccine to enter Argentina. The first batch of the drug arrived in the country on December 24, 2020. On December 29, vaccination began in Argentina, under which priority is given to medical workers. Vaccination centers opened in 23 provinces - in the capital, Buenos Aires alone, 600 vaccination centers are taken by patients who want to get the vaccine and line up in long lines.^[1]

2020: Start of supply of COVID-19 Sputnik V vaccine to Argentina

On December 10, 2020, the Russian coronavirus vaccines COVID-19 Direct Satellite V To Argentin Investment Fund and RDIF the South American government signed a contract to transfer 10 million doses of the drug.

The vaccine will allow Argentina to reserve a diversified portfolio of vaccines for coronavirus, according to the official website of Sputnik V.

Argentine President Alberto Fernandez announced that by the end of 2020 it will be possible to vaccinate about 300 thousand people and another 10 million residents in January-February 2021. The head of state said that he would be the first to vaccinate Satellite V, "so that no one is afraid," Bloomberg reports.

In November 2020, Alberto Fernandez announced an agreement to purchase 25 million doses of vaccines (that is, for 12.5 million people), which will arrive in the country in January-February 2021, and will primarily be distributed to risk groups-health workers, the security system, the older generation and people with chronic diseases.

In addition to Sputnik V, Argentina has entered into agreements on the supply of AstraZeneca and Covax vaccines. Clinical trials of the Russian coronavirus vaccine were not conducted in Argentina.

By December 10, 2020, Applications for the purchase of more than 1.2 billion doses of the Sputnik V vaccine came from more than 50 countries. The vaccine for deliveries to foreign markets will be produced by international partners of the Russian Direct Investment Fund in India, Brazil, China, Korea and other countries. Where the drugs will be delivered to Argentina is not reported. The cost of the contract is also unknown, but it was previously reported that the cost of one rate (two doses) is about $20, so Argentina could pay $100 million under the contract.^[2]

Notes